Low-dose donor CD8+ cells in the CD4-depleted graft prevent allogeneic marrow graft rejection and severe graft-versus-host disease for chronic myeloid leukemia patients in first chronic phase.

David Gallardo,J. García‐López,Anna Sureda,Carmen Canals,Christelle Ferrà,Jose A. Cancelas,Jj Berlanga,Salut Brunet,C Boqué,M. Picon,Carlos Torrico,Amill B,R Martino,Carmen Martínez,Ga Martín-Henao,Domingo-Albós A,Grañena A

Low-dose donor CD8+ cells in the CD4-depleted graft prevent allogeneic marrow graft rejection and severe graft-versus-host disease for chronic myeloid leukemia patients in first chronic phase.

1997

David Gallardo
J. García‐López
Anna Sureda
Carmen Canals
Christelle Ferrà
Jose A. Cancelas
Jj Berlanga
Salut Brunet
C Boqué
M. Picon
Carlos Torrico
Amill B
R Martino
Carmen Martínez
Ga Martín-Henao
Domingo-Albós A
Grañena A

Low-dose donor CD8 + cells in the CD4-depleted graft prevent allogeneic marrow graft rejection and severe graft-versus-host disease for chronic myeloid leukemia patients in first chronic phase

Keywords:

Diabetes mellitus
Bone marrow
Chronic myelogenous leukemia
CD8
Graft-versus-host disease
Myeloid leukemia
Immunology
Histocompatibility
Disease
Medicine
graft rejection
low dose

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations